[HTML][HTML] Targeted therapy, immunotherapy, and chemotherapy for chordoma

X Yang, P Li, Z Kang, W Li - Current Medicine, 2023 - Springer
Chordoma is a rare bone tumor often present in the skull base and spine. In addition, it is not
sensitive to radiotherapy that surgical resection is of great significance for the treatment of …

Immunotherapy as a potential treatment for chordoma: a review

SS Patel, JH Schwab - Current oncology reports, 2016 - Springer
Chordoma is a locally aggressive primary malignancy of the axial skeleton. The gold
standard for treatment is en bloc resection, with some centers now advocating for the use of …

[HTML][HTML] Molecular targeted therapy in the treatment of chordoma: a systematic review

T Meng, J Jin, C Jiang, R Huang, H Yin, D Song… - Frontiers in …, 2019 - frontiersin.org
Objectives: Chordoma is a rare bone malignancy that affects the spine and skull base.
Treatment dilemma leads to a high rate of local relapse and distant metastases. Molecular …

[HTML][HTML] Chordoma: a case series and review of the literature

O Alan, T Akin Telli, O Ercelep… - Journal of Medical Case …, 2018 - Springer
Background Chordoma is a rare malignant tumor of the skull base and axial skeleton, with
an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma have a …

[HTML][HTML] Medical treatment of advanced chordomas

V Colia, S Stacchiotti - European Journal of Cancer, 2017 - Elsevier
Chordoma is a very rare bone sarcoma that can arise from any site along the spine and from
the skull base. En bloc resection is the gold standard for treatment while radiation therapy …

The biological basis for modern treatment of chordoma

RJ Diaz, MD Cusimano - Journal of neuro-oncology, 2011 - Springer
Chordomas are rare malignant tumors arising in bone of the spheno-occiput, sacrum, and
vertebral column which can cause neurological deficit. Current management of chordoma …

Targeted therapy for chordoma: key molecular signaling pathways and the role of multimodal therapy

OO Akinduro, P Suarez-Meade, D Garcia, DA Brown… - Targeted …, 2021 - Springer
Background Chordoma is a rare but devastating tumor that arises in the cranial skull base or
spine. There are currently no US Food and Drug Administration-approved targeted therapies …

Shedding light on emerging therapeutic targets for chordoma

M Martinez Moreno, E Wang, C Schroeder… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Despite encouraging advances in radiation and surgical treatment, chordomas
remain resistant to chemotherapy and local recurrence is common. Although the primary …

[HTML][HTML] Chordoma: advances in biology and clinical management

P Gardner, J Bai, S Froelich, XR Yang… - Frontiers in Oncology, 2023 - frontiersin.org
Chordoma is a rare bony tumor, occurring across the neuraxis, most commonly in the
sacrum or skull base. Generally considered to be a malignant tumor, new evidence has …

Role of immunotherapy in treatment refractory chordomas: review of current evidence

AY Alexander, S Dhawan, AS Venteicher - Frontiers in Surgery, 2024 - frontiersin.org
Introduction Chordomas are aggressive tumors that are thought to arise from remnants of the
embryological notochord. They can arise along the ventromedial aspect of the sacrum …